+2 more ↓
69%
Finnrick rating
#4 of 108 BPC-157 vendors
8 of 9 classifiable tests passed
natural 89% · customers 4.6★ (4)
methodology · Purity focus
Finnrick analysis · BPC-157

One HXNet BPC-157 vial tested +70% over stated amount, despite otherwise low-concern identity and purity results. Later fills returned to range, but sparse batch identifiers keep the evidence less complete.

methodology →
vendor intelligence report
Vendor Intelligence Report: HXNet

Corporate records anchor HXNet to Hebei Xunou while the old domain is dead and sales have shifted into forum/Pastebin lanes. The report follows the HXTNT/KIRA/KARA reseller split, Janoshik chain-of-custody gaps, and documented refund/contamination disputes.

30 pages9 risk factors assessed2 Jul 2026
read the report
Peptides
#
Peptide
$/MG
Rating
N
1
GHK-Cu
$0.04
90%
11
2
Tirzepatide
$0.35
89%
51
3
Retatrutide
$0.60
82%
46
4
Semaglutide
$1.00
80%
5
6
BPC-157selected
$0.60
69%
9
7
Cagrilintide
$1.76
63%
15
8
Tesamorelin
$1.80
50%
11
9
CJC-1295
-
49%
4
10
TB-500
$1.36
43%
5
Contact channels
Rating trend
CUMULATIVE FINNRICK RATING
83%+65%+48%+30%+<30%29 Dec 2025: 46%1 Jan 2026: 49%15 Jan 2026: 53%26 Jan 2026: 50%15 Feb 2026: 55%18 Feb 2026: 59%10 Mar 2026: 63%6 Jun 2026: 67%24 Jun 2026: 69%9 Aug 2026: current 69%46%69%Dec 25Aug 26
Showing BPC-157 tests only
HXNet BPC-157 test history
COA-backed lab tests
DateResultTestLabPurityDosageLabelCOA
24 Jun 2026Pass
Tested
lab nameView COA
6 Jun 2026Pass
Tested
lab nameView COA
10 Mar 2026Pass
Tested
lab nameView COA
18 Feb 2026Pass
Tested
lab nameView COA
15 Feb 2026Pass
Tested
lab nameView COA
26 Jan 2026Fail
Tested
lab nameView COA
15 Jan 2026Pass
Tested
lab nameView COA
1 Jan 2026Pass
Tested
lab nameView COA
29 Dec 2025Pass
Tested
lab nameView COA

About HXNet test results from Finnrick

HXNet is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 10 peptides and 162 tests, including ratings, observed price signals, recent test dates, and correction history where available.

Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.

The most visible HXNet peptides in this dataset are Tirzepatide (51 tests), Semaglutide (5 tests) and BPC-157 (9 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.

Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 162 recent tests.

Corrections
No corrections.